Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Price-to-earnings ratio
Percentile
P71
Within normal range
vs 2Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 29.38 | +106.0% |
| 2024 | -486.05 | -2151.9% |
| 2023 | 23.69 | +170.1% |
| 2022 | -33.78 | -175.1% |
| 2021 | 44.96 | +108.3% |
| 2020 | -539.23 | -17229.7% |
| 2019 | 3.15 | -86.2% |
| 2018 | 22.77 | -90.1% |
| 2017 | 229.37 | +117.7% |
| 2016 | -1293.79 | - |